Top medicine articles for November 2014

A collection of some interesting medical articles published recently:

'To Burn Off Calories in This Soda, Walk 5 Miles' - new label http://buff.ly/1vzbCKH

Two new medications for IPF: Pirfenidone (Esbriet) affects scarring, Nintedanib (Ofev) is a kinase inhibitor http://buff.ly/1psam6m

80% of people have at least 1 distressing symptom in a given month, yet fewer than 1 in 4 persons sees a doctor. At least one third of common symptoms do not have a clear-cut, disease-based explanation. History and physical examination alone contribute 73% to 94% of the diagnostic information. The patient's history alone yields 75% of the diagnostic information. Most patients have multiple symptoms rather than a single symptom. Symptoms become chronic or recur in 20% to 25% of patients. http://buff.ly/1yf7S0w

A Small Practice's Fight to Stay Independent: Can It Work? Walk-ins only mornings work for this Chicago practice. 40% of patients seen at convenience clinics do not have a "medical home" or regular primary care physician http://buff.ly/1yfa87N

9 Brain Boosters to Prevent Memory Loss http://buff.ly/1ps8VVn

History and physical examination alone contribute 73% to 94% of the diagnostic information http://buff.ly/1yf7cIk

New 2-in-1 diabetes pill approved, Xigduo XR once-daily combines SGLT2 inhibitor dapagliflozin and metformin http://buff.ly/1ujxOtN

Running is a Life-Saver, Study Finds - running even as few as 5 to 10 minutes each day is fine http://buff.ly/10mYFrV

Fixing the EHR Beast: Old, Unfriendly, Decentralized, and Incompatible - by Medscape editor-at-large http://buff.ly/10mZGjy

How to Make Published Research True: many published research findings are false/exaggerated, 85% of resources wasted http://buff.ly/10n1Ekc

Men often don't appreciate their fathers until it's too late - Telegraph http://buff.ly/1tQDZp0

The articles were selected from Twitter and my RSS subscriptions. Please feel free to send suggestions for articles to clinicalcases AT gmail.com and you will receive acknowledgement in the next edition of this publication.